Össur hf. (OSSR.CO) Stock Analysis & AI Equity Report
Össur hf. (OSSR.CO) overview
Össur hf. (OSSR.CO) stock analysis and AI equity research. For the latest completed financial year, 2023, Össur hf. reported revenue of USD 786m and operating profit of USD 89.4m; the year-end share price was 27.45 DKK and market capitalisation was DKK 11,537m. Össur hf. is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Össur hf.'s valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-01. Data will be refreshed during report generation.
About Össur hf.
Össur develops, manufactures, and sells non-invasive orthopaedic products for people with limb loss, joint instability, and injury. Its portfolio spans prosthetics, bracing and supports, and patient care through owned orthotic and prosthetic clinics. The company serves clinicians and patients globally, with revenue driven by innovative mobility solutions and related services.
Generate the Össur hf. report
Össur hf. is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Össur hf. and represent the latest completed financial year (2023). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.